Harlan F. Weisman, Director at TFF Pharmaceuticals, Inc. (TFFP), bought 2,500 shares at $4.74 ($12K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
Open-market purchase of $12k TFFP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| TFFP | BUY | 2022-12-19 | $53K | — | Filing → |
| TFFP | BUY | 2022-05-20 | $38K | — | Filing → |
| TFFP | BUY | 2019-10-29 | $25K | — | Filing → |